Virtual approaches boost HIV self-testing in India
Nearly a third of babies with HIV given ART very soon after birth have no HIV antibodies two years later
Screening and early treatment reduce anal cancer risk by 57% in people living with HIV
Injected PrEP: cabotegravir maintains its advantage over four years
More focused HIV testing in PEPFAR countries yields results
New cases of hepatitis C declining in people with HIV as access to treatment broadens
COVID-19 vaccine rates in people with HIV mirror those in the general population
Point-of-care viral load tests did not improve viral suppression in Kenyan children
One person remains undetectable without HIV drugs almost four years after using an antibody-based therapy
